Patent

© Madeleine_Steinbach / Getty Images

Aker BioMarine acquires IP & equipment from Acasti Pharma Inc.

By Stephen Daniells

Aker BioMarine ASA is consolidating intellectual property (IP) in the krill space, with the announcement that it has acquired krill-related patents, pre-clinical and clinical data, and processing equipment from Acasti Pharma Inc.

Hi-Tech wins fees in patent case, expands distribution

Hi-Tech wins fees in patent case, expands distribution

By Hank Schultz

Controversial sports nutrition brand Hi-Tech Pharmaceuticals continues to make news with the announcement of a victory against a prolific patent enforcement entity and expansion of its distribution footprint.

© iStock / pilipenkoD

Aker, Neptune reach landmark krill oil licensing agreement

By Hank Schultz

The Thirty Years War that reshaped Europe featured myriad twists and turns. The Krill Wars have, too, with the latest being a final, formal burying of the hatchet between the two principal players, Aker BioMarine and Neptune Technologies and Bioressources.

NAI settles prolonged beta alanine patent suit against Woodbolt

NAI settles prolonged beta alanine patent suit against Woodbolt

By Hank Schultz

Natural Alternatives International Inc. has settled one of its longest-standing patent infringement cases on its CarnoSyn beta-alanine ingredient. Defendant Woodbolt Distribution Inc. has agreed to a licensing arrangement in a case that has gone on for...

Neptune's European patent on krill oil revoked

Neptune's European patent on krill oil revoked

By Hank Schultz

The European Patent Office has revoked one of the patents held by krill oil supplier Neptune Technologies & Bioressources.  As has become de rigueur in the IP battle among krill companies, the various players disagree about what the action means.

Neptune and Aker facing off in court yet again

Krill wars

Neptune and Aker facing off in court yet again

By RJ Whitehead

Australia is the site of the latest battle between Neptune and Aker Biomarine. In addition to patent strife between the two krill majors in American courts, Canadian Neptune has now announced that it filed opposition to an Aker patent application earlier...

US Patent Office to re-examine second Neptune patent

US Patent Office to re-examine second Neptune patent

By Elaine Watson

The US Patent and Trademark Office (USPTO) has granted a request from Aker BioMarine to re-examine another US patent recently awarded to its arch rival Neptune Technologies & Bioressources.

Krill oil specialist Neptune predicts 17-22% rise in Q3 revenues

Krill oil specialist Neptune predicts 17-22% rise in Q3 revenues

By Elaine Watson

Bosses at Canadian krill oil firm Neptune Technologies & Bioressources are confident that third quarter revenues (three months to Nov 30) will be in the $5m to $5.25m range compared with $4.29m in the same period last year, representing a 17-22% rise.

Neptune secures US patent for krill cardio health benefits

Neptune secures US patent for krill cardio health benefits

By Elaine Watson

Neptune Technologies & Bioressources has bolstered its intellectual property portfolio further after securing a new US patent (No. 8,057,825) awarding it the exclusive use of krill extracts in the US as a method for reducing cholesterol, platelet...

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All